NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, withdrew its plans for an initial public offering on Wednesday. It had filed to raise $75 million by offering 6 million shares at a price range of $11.25 to...read more
Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include...read more
No IPOs debuted this past, as two companies previously scheduled to list (NTHI and RAN) kicked the can down the road. Seven IPOs and one SPAC submitted initial filings this week. Meanwhile, social media platform Reddit (RDDT) launched its...read more
Two listings are currently scheduled for the week ahead, although one is excluded from our IPO stats. Other issuers may join the calendar throughout the week. Phase 2 brain cancer biotech NeOnc Technologies (NTHI) plans to raise $75 million...read more
Brain cancer biotech NeOnc Technologies withdraws $75 million IPO
NeOnc Technologies Holdings, a Phase 2 biotech developing intranasal and oral therapies for brain cancer, withdrew its plans for an initial public offering on Wednesday. It had filed to raise $75 million by offering 6 million shares at a price range of $11.25 to...read more
US IPO Week Ahead: IPO market starts with a quiet week as potential launches loom
Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include...read more
US IPO Weekly Recap: 7 new filers join the pipeline as Reddit and Auna launch
No IPOs debuted this past, as two companies previously scheduled to list (NTHI and RAN) kicked the can down the road. Seven IPOs and one SPAC submitted initial filings this week. Meanwhile, social media platform Reddit (RDDT) launched its...read more
US IPO Week Ahead: Oncology biotech and drone maker set to debut
Two listings are currently scheduled for the week ahead, although one is excluded from our IPO stats. Other issuers may join the calendar throughout the week. Phase 2 brain cancer biotech NeOnc Technologies (NTHI) plans to raise $75 million...read more